TY - JOUR
T1 - Cholangiokines
T2 - undervalued modulators in the hepatic microenvironment
AU - Cai, Xiurong
AU - Tacke, Frank
AU - Guillot, Adrien
AU - Liu, Hanyang
N1 - Publisher Copyright:
Copyright © 2023 Cai, Tacke, Guillot and Liu.
PY - 2023
Y1 - 2023
N2 - The biliary epithelial cells, also known as cholangiocytes, line the intra- and extrahepatic bile ducts, forming a barrier between intra- and extra-ductal environments. Cholangiocytes are mostly known to modulate bile composition and transportation. In hepatobiliary diseases, bile duct injury leads to drastic alterations in cholangiocyte phenotypes and their release of soluble mediators, which can vary depending on the original insult and cellular states (quiescence, senescence, or proliferation). The cholangiocyte-secreted cytokines (also termed cholangiokines) drive ductular cell proliferation, portal inflammation and fibrosis, and carcinogenesis. Hence, despite the previous consensus that cholangiocytes are bystanders in liver diseases, their diverse secretome plays critical roles in modulating the intrahepatic microenvironment. This review summarizes recent insights into the cholangiokines under both physiological and pathological conditions, especially as they occur during liver injury-regeneration, inflammation, fibrosis and malignant transformation processes.
AB - The biliary epithelial cells, also known as cholangiocytes, line the intra- and extrahepatic bile ducts, forming a barrier between intra- and extra-ductal environments. Cholangiocytes are mostly known to modulate bile composition and transportation. In hepatobiliary diseases, bile duct injury leads to drastic alterations in cholangiocyte phenotypes and their release of soluble mediators, which can vary depending on the original insult and cellular states (quiescence, senescence, or proliferation). The cholangiocyte-secreted cytokines (also termed cholangiokines) drive ductular cell proliferation, portal inflammation and fibrosis, and carcinogenesis. Hence, despite the previous consensus that cholangiocytes are bystanders in liver diseases, their diverse secretome plays critical roles in modulating the intrahepatic microenvironment. This review summarizes recent insights into the cholangiokines under both physiological and pathological conditions, especially as they occur during liver injury-regeneration, inflammation, fibrosis and malignant transformation processes.
KW - biliary epithelial cells
KW - cellular senescence
KW - cholangiocyte secretome
KW - cholangiopathies
KW - ductular reaction
KW - fibrosis
KW - hepatic carcinogenesis
KW - inflammation
UR - http://www.scopus.com/inward/record.url?scp=85160969798&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2023.1192840
DO - 10.3389/fimmu.2023.1192840
M3 - Review article
C2 - 37261338
AN - SCOPUS:85160969798
SN - 1664-3224
VL - 14
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 1192840
ER -